These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 25139025)
1. Co-administration of ABT-737 and SAHA induces apoptosis, mediated by Noxa upregulation, Bax activation and mitochondrial dysfunction in PTEN-intact malignant human glioma cell lines. Foster KA; Jane EP; Premkumar DR; Morales A; Pollack IF J Neurooncol; 2014 Dec; 120(3):459-72. PubMed ID: 25139025 [TBL] [Abstract][Full Text] [Related]
2. ABT-737 synergizes with bortezomib to induce apoptosis, mediated by Bid cleavage, Bax activation, and mitochondrial dysfunction in an Akt-dependent context in malignant human glioma cell lines. Premkumar DR; Jane EP; DiDomenico JD; Vukmer NA; Agostino NR; Pollack IF J Pharmacol Exp Ther; 2012 Jun; 341(3):859-72. PubMed ID: 22393246 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of phosphatidylinositol 3-kinase/AKT signaling by NVP-BKM120 promotes ABT-737-induced toxicity in a caspase-dependent manner through mitochondrial dysfunction and DNA damage response in established and primary cultured glioblastoma cells. Jane EP; Premkumar DR; Morales A; Foster KA; Pollack IF J Pharmacol Exp Ther; 2014 Jul; 350(1):22-35. PubMed ID: 24741074 [TBL] [Abstract][Full Text] [Related]
4. BH3 mimetic ABT-737 and a proteasome inhibitor synergistically kill melanomas through Noxa-dependent apoptosis. Miller LA; Goldstein NB; Johannes WU; Walton CH; Fujita M; Norris DA; Shellman YG J Invest Dermatol; 2009 Apr; 129(4):964-71. PubMed ID: 18987671 [TBL] [Abstract][Full Text] [Related]
5. Cucurbitacin-I inhibits Aurora kinase A, Aurora kinase B and survivin, induces defects in cell cycle progression and promotes ABT-737-induced cell death in a caspase-independent manner in malignant human glioma cells. Premkumar DR; Jane EP; Pollack IF Cancer Biol Ther; 2015; 16(2):233-43. PubMed ID: 25482928 [TBL] [Abstract][Full Text] [Related]
6. ABT-737 promotes tBid mitochondrial accumulation to enhance TRAIL-induced apoptosis in glioblastoma cells. Cristofanon S; Fulda S Cell Death Dis; 2012 Nov; 3(11):e432. PubMed ID: 23190604 [TBL] [Abstract][Full Text] [Related]
7. Bim upregulation by histone deacetylase inhibitors mediates interactions with the Bcl-2 antagonist ABT-737: evidence for distinct roles for Bcl-2, Bcl-xL, and Mcl-1. Chen S; Dai Y; Pei XY; Grant S Mol Cell Biol; 2009 Dec; 29(23):6149-69. PubMed ID: 19805519 [TBL] [Abstract][Full Text] [Related]
8. Activity of vincristine, L-ASP, and dexamethasone against acute lymphoblastic leukemia is enhanced by the BH3-mimetic ABT-737 in vitro and in vivo. Kang MH; Kang YH; Szymanska B; Wilczynska-Kalak U; Sheard MA; Harned TM; Lock RB; Reynolds CP Blood; 2007 Sep; 110(6):2057-66. PubMed ID: 17536015 [TBL] [Abstract][Full Text] [Related]
9. Platinum compounds sensitize ovarian carcinoma cells to ABT-737 by modulation of the Mcl-1/Noxa axis. Simonin K; N'Diaye M; Lheureux S; Loussouarn C; Dutoit S; Briand M; Giffard F; Brotin E; Blanc-Fournier C; Poulain L Apoptosis; 2013 Apr; 18(4):492-508. PubMed ID: 23344663 [TBL] [Abstract][Full Text] [Related]
10. Sorafenib Sensitizes Glioma Cells to the BH3 Mimetic ABT-737 by Targeting MCL1 in a STAT3-Dependent Manner. Kiprianova I; Remy J; Milosch N; Mohrenz IV; Seifert V; Aigner A; Kögel D Neoplasia; 2015 Jul; 17(7):564-73. PubMed ID: 26297434 [TBL] [Abstract][Full Text] [Related]
11. γ-Secretase inhibition promotes cell death, Noxa upregulation, and sensitization to BH3 mimetic ABT-737 in human breast cancer cells. Séveno C; Loussouarn D; Bréchet S; Campone M; Juin P; Barillé-Nion S Breast Cancer Res; 2012 Jun; 14(3):R96. PubMed ID: 22703841 [TBL] [Abstract][Full Text] [Related]
12. Bortezomib-induced sensitization of malignant human glioma cells to vorinostat-induced apoptosis depends on reactive oxygen species production, mitochondrial dysfunction, Noxa upregulation, Mcl-1 cleavage, and DNA damage. Premkumar DR; Jane EP; Agostino NR; DiDomenico JD; Pollack IF Mol Carcinog; 2013 Feb; 52(2):118-33. PubMed ID: 22086447 [TBL] [Abstract][Full Text] [Related]
13. Targeting ERK1/2-bim signaling cascades by BH3-mimetic ABT-737 as an alternative therapeutic strategy for oral cancer. Shin JA; Kim LH; Lee SJ; Jeong JH; Jung JY; Lee HN; Hong IS; Cho SD Oncotarget; 2015 Nov; 6(34):35667-83. PubMed ID: 26447615 [TBL] [Abstract][Full Text] [Related]
14. The putative BH3 mimetic S1 sensitizes leukemia to ABT-737 by increasing reactive oxygen species, inducing endoplasmic reticulum stress, and upregulating the BH3-only protein NOXA. Soderquist R; Pletnev AA; Danilov AV; Eastman A Apoptosis; 2014 Jan; 19(1):201-9. PubMed ID: 24072590 [TBL] [Abstract][Full Text] [Related]
15. Alterations in the Noxa/Mcl-1 axis determine sensitivity of small cell lung cancer to the BH3 mimetic ABT-737. Hauck P; Chao BH; Litz J; Krystal GW Mol Cancer Ther; 2009 Apr; 8(4):883-92. PubMed ID: 19372561 [TBL] [Abstract][Full Text] [Related]
16. YM-155 potentiates the effect of ABT-737 in malignant human glioma cells via survivin and Mcl-1 downregulation in an EGFR-dependent context. Jane EP; Premkumar DR; DiDomenico JD; Hu B; Cheng SY; Pollack IF Mol Cancer Ther; 2013 Mar; 12(3):326-38. PubMed ID: 23325792 [TBL] [Abstract][Full Text] [Related]
17. Mechanism of synergy of N-(4-hydroxyphenyl)retinamide and ABT-737 in acute lymphoblastic leukemia cell lines: Mcl-1 inactivation. Kang MH; Wan Z; Kang YH; Sposto R; Reynolds CP J Natl Cancer Inst; 2008 Apr; 100(8):580-95. PubMed ID: 18398104 [TBL] [Abstract][Full Text] [Related]
18. Mcl-1 Phosphorylation defines ABT-737 resistance that can be overcome by increased NOXA expression in leukemic B cells. Mazumder S; Choudhary GS; Al-Harbi S; Almasan A Cancer Res; 2012 Jun; 72(12):3069-79. PubMed ID: 22525702 [TBL] [Abstract][Full Text] [Related]
19. ABT-737 induces apoptosis in mantle cell lymphoma cells with a Bcl-2high/Mcl-1low profile and synergizes with other antineoplastic agents. Touzeau C; Dousset C; Bodet L; Gomez-Bougie P; Bonnaud S; Moreau A; Moreau P; Pellat-Deceunynck C; Amiot M; Le Gouill S Clin Cancer Res; 2011 Sep; 17(18):5973-81. PubMed ID: 21821698 [TBL] [Abstract][Full Text] [Related]
20. Induction of Noxa sensitizes human colorectal cancer cells expressing Mcl-1 to the small-molecule Bcl-2/Bcl-xL inhibitor, ABT-737. Okumura K; Huang S; Sinicrope FA Clin Cancer Res; 2008 Dec; 14(24):8132-42. PubMed ID: 19088028 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]